ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022 Updates on Neoadjuvant Cabozantinib in Locally Advanced Non-Metastatic ccRCC: Phase 2 Study

64 views
February 24, 2022
Comments 0
Login to view comments. Click here to Login